Home/Filings/4/0001104659-22-088076
4//SEC Filing

DAMASIO JOSEPH LUIS JR 4

Accession 0001104659-22-088076

CIK 0001563665other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 6:06 PM ET

Size

5.6 KB

Accession

0001104659-22-088076

Insider Transaction Report

Form 4
Period: 2022-08-08
DAMASIO JOSEPH LUIS JR
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-08-08+116,156116,156 total
    Exercise: $5.00Exp: 2032-08-08Common Stock, par value $0.01 per share (116,156 underlying)
Footnotes (1)
  • [F1]Subject to continued employment through the applicable vesting dates, these shares vest in four equal annual increments on each anniversary of the grant date.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001450080

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:06 PM ET
Size
5.6 KB